IL6 and metabolic dysfunction-associated steatotic liver disease: Patients in the NAFLD group had a higher leukocyte count (7.4 × 109/L, IQR 5.6–10 vs. 5.7 × 109/L, IQR 4.8–7.1, p = 0.028), platelet count (219 × 109/L, IQR 160–270 vs. 176 × 109, IQR 121–236, p = 0.011), gamma-glutamyl transferase level (61 IU/L, IQR 42–131 vs. 38 IU/L, IQR 24–62, p = 0.018), C-reactive protein level (140 mg/L, IQR 71–221 vs. 90 mg/L, IQR 39–139, p = 0.032), and IL-6 level (87 pg/L, IQR 15–150 vs. 41 pg/L, IQR 14–62, p = 0.035).